Clesson Turner

1.7k total citations
40 papers, 499 citations indexed

About

Clesson Turner is a scholar working on Genetics, Molecular Biology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Clesson Turner has authored 40 papers receiving a total of 499 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Genetics, 11 papers in Molecular Biology and 8 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Clesson Turner's work include BRCA gene mutations in cancer (13 papers), Cancer Genomics and Diagnostics (7 papers) and Genomics and Rare Diseases (5 papers). Clesson Turner is often cited by papers focused on BRCA gene mutations in cancer (13 papers), Cancer Genomics and Diagnostics (7 papers) and Genomics and Rare Diseases (5 papers). Clesson Turner collaborates with scholars based in United States, United Kingdom and Australia. Clesson Turner's co-authors include Rachel E. Ellsworth, Darrell L. Ellsworth, Leslie G. Biesecker, N R Dennis, P. A. Jacobs, Jennifer J. Johnston, Marjorie Rosenberg, Craig D. Shriver, Christina Killoran and D.N. Cooper and has published in prestigious journals such as Journal of Clinical Investigation, SHILAP Revista de lepidopterología and Biological Psychiatry.

In The Last Decade

Clesson Turner

36 papers receiving 477 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Clesson Turner United States 12 243 224 63 61 57 40 499
Tatiana Tvrdik United States 11 224 0.9× 226 1.0× 129 2.0× 60 1.0× 31 0.5× 16 524
Sofia Kitsiou‐Tzeli Greece 14 186 0.8× 219 1.0× 33 0.5× 142 2.3× 54 0.9× 31 513
Fang Xu China 12 146 0.6× 122 0.5× 36 0.6× 76 1.2× 27 0.5× 40 352
Stanisław Zajączek Poland 10 129 0.5× 198 0.9× 26 0.4× 38 0.6× 37 0.6× 36 354
Eden Haverfield United States 13 277 1.1× 241 1.1× 44 0.7× 95 1.6× 28 0.5× 23 536
María Juliana Ballesta‐Martínez Spain 14 274 1.1× 308 1.4× 22 0.3× 82 1.3× 33 0.6× 33 569
Sara L. Bristow United States 13 185 0.8× 96 0.4× 40 0.6× 108 1.8× 35 0.6× 38 412
Esther Vamos Belgium 15 179 0.7× 286 1.3× 22 0.3× 85 1.4× 46 0.8× 21 533
Isabelle Guilleret Switzerland 13 156 0.6× 615 2.7× 77 1.2× 32 0.5× 41 0.7× 16 832
Kamilla Schlade‐Bartusiak Canada 13 160 0.7× 164 0.7× 82 1.3× 61 1.0× 20 0.4× 27 334

Countries citing papers authored by Clesson Turner

Since Specialization
Citations

This map shows the geographic impact of Clesson Turner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Clesson Turner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Clesson Turner more than expected).

Fields of papers citing papers by Clesson Turner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Clesson Turner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Clesson Turner. The network helps show where Clesson Turner may publish in the future.

Co-authorship network of co-authors of Clesson Turner

This figure shows the co-authorship network connecting the top 25 collaborators of Clesson Turner. A scholar is included among the top collaborators of Clesson Turner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Clesson Turner. Clesson Turner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Singh-Miller, Nicholas, Tracey M. Ferrara, Jennifer J. Johnston, et al.. (2024). O09: Phenome-wide studies of hereditary transthyretin amyloidosis in the All of Us research program. SHILAP Revista de lepidopterología. 2. 101013–101013.
2.
Wilkerson, Matthew D., Daniel Hupalo, Joshua C. Gray, et al.. (2023). Uncommon Protein-Coding Variants Associated With Suicide Attempt in a Diverse Sample of U.S. Army Soldiers. Biological Psychiatry. 96(1). 15–25. 2 indexed citations
3.
Roger, Véronique L., et al.. (2023). Prevalence of Heart Failure Stages in a Universal Health Care System: The Military Health System Experience. The American Journal of Medicine. 136(11). 1079–1086.e1. 1 indexed citations
4.
5.
Paschall, Justin, Suiyuan Zhang, Morgan Similuk, et al.. (2023). Genotype first: Clinical genomics research through a reverse phenotyping approach. The American Journal of Human Genetics. 110(1). 3–12. 32 indexed citations
6.
Lee, Jeannie K., Tulio Bueso, Jong-Yeol Kim, et al.. (2023). ATP1A1-linked diseases require a malfunctioning protein product from one allele. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1871(1). 119572–119572. 1 indexed citations
7.
Turner, Clesson, et al.. (2022). Influence of germline test results on surgical decision making in women with invasive breast cancer. Cancer Genetics. 266-267. 81–85. 2 indexed citations
8.
Turner, Clesson, et al.. (2022). Eligibility, uptake and response to germline genetic testing in women with DCIS. Frontiers in Oncology. 12. 918757–918757. 3 indexed citations
9.
Turner, Clesson, et al.. (2021). Genetic testing in Non-Hispanic Black women with breast cancer treated within an equal-access healthcare system. Genetics in Medicine. 24(1). 232–237. 2 indexed citations
10.
Rummel, Seth, et al.. (2020). Frequency and spectrum of mutations across 94 cancer predisposition genes in African American women with invasive breast cancer. Familial Cancer. 20(3). 181–187. 5 indexed citations
11.
Turner, Clesson, et al.. (2020). Heritability of Low ER Staining/HER2-Breast Tumors: Are We Missing an Opportunity for Germline Testing?. Genes. 11(12). 1469–1469. 4 indexed citations
12.
Turner, Clesson, Teri A. Manolio, Mark C. Haigney, et al.. (2018). Return of secondary findings in genomic sequencing: Military implications. Molecular Genetics & Genomic Medicine. 7(2). e00483–e00483. 6 indexed citations
13.
Castro, Mauricio De & Clesson Turner. (2017). Military genomics: a perspective on the successes and challenges of genomic medicine in the Armed Services. Molecular Genetics & Genomic Medicine. 5(6). 617–620. 9 indexed citations
14.
Brohl, Andrew S., Rajesh Patidar, Clesson Turner, et al.. (2017). Frequent inactivating germline mutations in DNA repair genes in patients with Ewing sarcoma. Genetics in Medicine. 19(8). 955–958. 56 indexed citations
15.
Blackburn, Heather L., Bradley W. Schroeder, Clesson Turner, et al.. (2015). Management of Incidental Findings in the Era of Next-generation Sequencing. Current Genomics. 16(3). 159–174. 32 indexed citations
16.
Turner, Clesson, et al.. (2013). Diagnosis of Bardet-Biedl Syndrome in Consecutive Pregnancies Affected with Echogenic Kidneys and Polydactyly in a Consanguineous Couple. SHILAP Revista de lepidopterología. 2013. 1–3. 1 indexed citations
17.
Rees, Matthew G., David Ng, Clesson Turner, et al.. (2011). Correlation of rare coding variants in the gene encoding human glucokinase regulatory protein with phenotypic, cellular, and kinetic outcomes. Journal of Clinical Investigation. 122(1). 205–217. 36 indexed citations
18.
Solomon, Benjamin D., Clesson Turner, Darren Klugman, & Susan Sparks. (2007). Trisomy 9 mosaicism and XX sex reversal. American Journal of Medical Genetics Part A. 143A(22). 2688–2691. 4 indexed citations
19.
Turner, Clesson, et al.. (2000). Seven ring (X) chromosomes lacking the XIST locus, six with an unexpectedly mild phenotype. Human Genetics. 106(1). 93–93. 39 indexed citations
20.
Kuntsi, Jonna, David Skuse, Kate Elgar, Emma Morris, & Clesson Turner. (2000). Ring‐X chromosomes: their cognitive and behavioural phenotype. Annals of Human Genetics. 64(4). 295–305. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tatiana Tvrdik Breakdown of academic impact, for papers by Sofia Kitsiou‐Tzeli Breakdown of academic impact, for papers by Fang Xu Breakdown of academic impact, for papers by Stanisław Zajączek Breakdown of academic impact, for papers by Eden Haverfield Breakdown of academic impact, for papers by María Juliana Ballesta‐Martínez Breakdown of academic impact, for papers by Sara L. Bristow Breakdown of academic impact, for papers by Esther Vamos Breakdown of academic impact, for papers by Isabelle Guilleret Breakdown of academic impact, for papers by Kamilla Schlade‐Bartusiak
Rankless by CCL
2026